Quadratic trajectories of brain myelin content: Unifying construct for neuropsychiatric disorders

Neurobiology of Aging

Volumn 25, Issue 1, 2004, Pages 49-62

  Bartzokis, George ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Gtr Los Angeles VA Hlthcare System   (United States)

Author keywords

ADHD; Aging; Alpha synuclein; Alzheimer; Amyloid; Autism; Brain development; Cholesterol; Degeneration; Dementia; Free radicals; Frontotemporal; FTD; Gender; Head Trauma; Iron; Learning disability; Lewy body; Myelin; Oligodendrocytes; Parkinson; Tau; White matter

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN PROTEIN; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; MYELIN; SYNUCLEIN; TAU PROTEIN;

ADULTHOOD; AGING; ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN DEVELOPMENT; CHILDHOOD; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DEMYELINATION; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; ENZYME INHIBITION; FRONTOTEMPORAL DEMENTIA; GENETIC RISK; HALLERVORDEN SPATZ DISEASE; HUMAN; LANGUAGE DEVELOPMENT; LANGUAGE DISABILITY; LEARNING DISORDER; LEWY BODY; LIFESPAN; MEMORY DISORDER; MENTAL DISEASE; MYELINATION; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SENESCENCE; SENILE PLAQUE; SEX DIFFERENCE; SHY DRAGER SYNDROME; SPEECH DEVELOPMENT; SPEECH DISORDER; SUBSTANCE ABUSE;

EID: 0346220384     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.08.001     Document Type: Note

References (169)

1. Aleman A., Kahn R.S., Selten J.P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen. Psychiatry. 60:2003;565-571.
2. Anderson B., Southern B.D., Powers R.E. Anatomic asymmetries of the posterior superior temporal lobes: a postmortem study. Neuropsychiatry Neuropsychol. Behav. Neurol. 12:1999;247-254.
3. Arendt T., Bruckner M.K., Lange M., Bigl V. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem. Int. 21:1992;381-396.
4. Arima K., Hirai S., Sunohara N., Aoto K., Izumiyama Y., Ueda K.et al. Cellular co-localization of phosphorylated tau- and nacp/alpha-synuclein- epitopes in lewy bodies in sporadic parkinson's disease and in dementia with lewy bodies. Brain Res. 843:1999;53-61.
5. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen. Psychiatry. 55:1998;225-232.
6. Atkins C.M., Sweatt J.D. Reactive oxygen species mediate activity-dependent neuron-glia signaling in output fibers of the hippocampus. J. Neurosci. 19:1999;7241-7248.
7. Atkins C.M., Yon M., Groome N.P., Sweatt J.D. Regulation of myelin basic protein phosphorylation by mitogen-activated protein kinase during increased action potential firing in the hippocampus. J. Neurochem. 73:1999;1090-1097.
8. Barker W.W., Luis C.A., Kashuba A., Luis M., Harwood D.G., Loewenstein D.et al. Relative frequencies of Alzheimer disease, lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of florida brain bank. Alzheimer Dis. Assoc. Disord. 16:2002;203-212.
9. Bartels C.F., Jensen F.S., Lockridge O., van der Spek A.F., Rubinstein H.M., Lubrano T.et al. DNA mutation associated with the human butyrylcholinesterase k-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet. 50:1992;1086-1103.
10. Bartzokis G. Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology. 27:2002;672-683.
11. Bartzokis, G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2003;(this issue).
12. Bartzokis G. Myelination and brain electrophysiology in healthy and schizophrenic individuals. Neuropsychopharmacology. 28:2003;1217-1218.
13. Bartzokis G., Beckson M., Hance D.B., Marx P., Foster J.A., Marder S.R. Mri evaluation of age-related increase of brain iron in young adult and older normal males. Magn. Reson. Imaging. 15:1997;29-35.
14. Bartzokis G., Beckson M., Lu P.H., Edwards N., Bridge P., Mintz J. Brain maturation may be arrested in chronic cocaine addicts. Biol. Psychiatry. 51:2002;605-611.
15. Bartzokis G., Beckson M., Lu P.H., Nuechterlein K.H., Edwards N., Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen. Psychiatry. 58:2001;461-465.
16. Bartzokis G., Cummings J., Perlman S., Hance D.B., Mintz J. Increased basal ganglia iron levels in huntington disease. Arch. Neurol. 56:1999;569-574.
17. Bartzokis G., Cummings J.L., Markham C.H., Marmarelis P.Z., Treciokas L.J., Tishler T.A.et al. Mri evaluation of brain iron in earlier- and later-onset parkinson's disease and normal subjects. Magn. Reson. Imaging. 17:1999;213-222.
18. Bartzokis G., Cummings J.L., Sultzer D., Henderson V.W., Nuechterlein K.H., Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch. Neurol. 60:2003;393-398.
19. Bartzokis G., Nuechterlein K.H., Lu P.H., Gitlin M., Rogers S., Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry. 53:2003;412-421.
20. Bartzokis G., Sultzer D., Cummings B.J., Holt L.E., Hance D.B., Henderson V.W.et al. In vivo evaluation of brain iron in Alzheimer's disease and normal controls using magnetic resonance imaging. Arch. Gen. Psychiatry. 57:2000;47-53.
21. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings J. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. 2003, under review.
22. Belin P., Zilbovicius M., Crozier S., Thivard L., Fontaine A., Masure M.C.et al. Lateralization of speech and auditory temporal processing. J. Cogn. Neurosci. 10:1998;536-540.
23. Benes FM. A disturbance of late myelination as a trigger for Alzheimer's disease. Neurobiol Aging 2003;(this issue).
24. Benes F.M., Turtle M., Khan Y., Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatry. 51:1994;477-484.
25. Beyer K., Lao J.I., Latorre P., Riutort N., Matute B., Fernandez-Figueras M.T.et al. Methionine synthase polymorphism is a risk factor for Alzheimer disease. Neuroreport. 14:2003;1391-1394.
26. Bozikas V.P., Kovari E., Bouras C., Karavatos A. Neurofibrillary tangles in elderly patients with late onset schizophrenia. Neurosci. Lett. 324:2002;109-112.
27. Braak H, Braak E. Temporal sequence of Alzheimer's disease-ralated pathology. In: Jones E, Peters A, editors. Cerebral cortex: neurodegenerative and age-related changes in structure and function of cerebral cortex, vol. 14. New York: Plenium Press; 1999. p. 475-512.
28. Braak H, Tredici KD. Open peer commentary: poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 2003;(this issue).
29. Brody B.A., Kinney H.C., Kloman A.S., Gilles F.H. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J. Neuropathol. Exp. Neurol. 46:1987;283-301.
30. Bronge L. Magnetic resonance imaging in dementia. A study of brain white matter changes. Acta Radiol Suppl 2002:1-32.
31. Burn D.J., Jaros E. Multiple system atrophy: cellular and molecular pathology. Mol. Pathol. 54:2001;419-426.
32. Butterfield D.A., Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122:2001;945-962.
33. Campbell B.A., Lytle L.D., Fibiger H.C. Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science. 166:1969;635-637.
34. Carper R.A., Moses P., Tigue Z.D., Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage. 16:2002;1038-1051.
35. Carson K.A., Geula C., Mesulam M.M. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Brain Res. 540:1991;204-208.
36. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S.et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 288:2002;1740-1748.
37. Chow T.W., Miller B.L., Boone K., Mishkin F., Cummings J.L. Frontotemporal dementia classification and neuropsychiatry. Neurolog. 8:2002;263-269.
38. Connor JR. Myelin breakdown in Alzheimer's disease: a commentary. Neurobiol Aging 2003;(this issue).
39. Constantino J.N., Todd R.D. Autistic traits in the general population: a twin study. Arch Gen. Psychiatry. 60:2003;524-530.
40. Culvenor J.G., Rietze R.L., Bartlett P.F., Masters C.L., Li Q.X. Oligodendrocytes from neural stem cells express alpha-synuclein: increased numbers from presenilin 1 deficient mice. Neuroreport. 13:2002;1305-1308.
41. Dev K.K., Hofele K., Barbieri S., Buchman V.L., van der Putten H. Part ii: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology. 45:2003;14-44.
42. Dickson D.W., Bergeron C., Chin S.S., Duyckaerts C., Horoupian D., Ikeda K.et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol. 61:2002;935-946.
43. Dineley K.T., Xia X., Bui D., Sweatt J.D., Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J. Biol. Chem. 277:2002;22768- 22780.
44. Drews U. Cholinesterase in embryonic development. Prog. Histochem. Cytochem. 7:1975;1-52.
45. Dubovy P., Haninec P. Non-specific cholinesterase activity of the developing peripheral nerves and its possible function in cells in intimate contact with growing axons of chick embryo. Int. J. Dev. Neurosci. 8:1990;589-602.
46. Duffy F.H., McAnulty G.B., Albert M.S. The pattern of age-related differences in electrophysiological activity of healthy males and females. Neurobiol. Aging. 14:1993;73-84.
47. Dustman R.E., Emmerson R.Y., Shearer D.E. Life span changes in electrophysiological measures of inhibition. Brain Cogn. 30:1996;109-126.
48. Fell J., Klaver P., Lehnertz K., Grunwald T., Schaller C., Elger C.E.et al. Human memory formation is accompanied by rhinal-hippocampal coupling and decoupling. Nat. Neurosci. 4:2001;1259-1264.
49. Felts P.A., Baker T.A., Smith K.J. Conduction in segmentally demyelinated mammalian central axons. J. Neurosci. 17:1997;7267-7277.
50. Fleck D.E., Sax K.W., Strakowski S.M. Reaction time measures of sustained attention differentiate bipolar disorder from schizophrenia. Schizophr. Res. 52:2001;251-259.
51. Friede R.L. A comparative histochemical mapping of the distribution of butyryl cholinesterase in the brains of four species of mammals, including man. Acta Anat. 66:1967;161-177.
52. Fuster J.M. Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatr. Scand. Suppl. 395:1999;51-57.
53. Gandy S. Estrogen and neurodegeneration. Neurochem. Res. 28:2003;1003-1008.
54. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen. Psychiatry. 55:1998;809-815.
55. Gartner U., Hartig W., Brauer K., Bruckner G., Arendt T. Electron microscopic evidence for different myelination of rat septohippocampal fibres. Neuroreport. 12:2001;17-20.
56. Ge Y., Grossman R.I., Babb J.S., Rabin M.L., Mannon L.J., Kolson D.L. Age-related total gray matter and white matter changes in normal adult brain. Part i: volumetric mr imaging analysis. AJNR Am. J. Neuroradiol. 23:2002;1327-1333.
57. Ge Y., Grossman R.I., Babb J.S., Rabin M.L., Mannon L.J., Kolson D.L. Age-related total gray matter and white matter changes in normal adult brain. Part ii: quantitative magnetization transfer ratio histogram analysis. AJNR Am. J. Neuroradiol. 23:2002;1334-1341.
58. Geddes J.F., Vowles G.H., Hackshaw A.K., Nickols C.D., Scott I.S., Whitwell H.L. Neuropathology of inflicted head injury in children. li. Microscopic brain injury in infants. Brain. 124:2001;1299-1306.
59. Geddes J.F., Vowles G.H., Nicoll J.A., Revesz T. Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol. (Berl). 98:1999;171-178.
60. Gerber M.R., Connor J.R. Do oligodendrocytes mediate iron regulation in the human brain? Ann. Neurol. 26:1989;95-98.
61. Geschwind D.H., Robidoux J., Alarcon M., Miller B.L., Wilhelmsen K.C., Cummings J.L., Nasreddine Z.S. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann. Neurol. 50:2001;741-746.
62. Ghebremedhin E., Thal D.R., Schultz C., Braak H. Age-dependent association between butyrylcholinesterase k-variant and Alzheimer disease-related neuropathology in human brains. Neurosci. Lett. 320:2002;25-28.
63. Giacobini E., Spiegel R., Enz A., Veroff A.E., Cutler N.R. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit. J. Neural. Transm. 109:2002;1053-1065.
64. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., Kotzbauer P.T.et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 300:2003;636-640.
65. Gibb W.R., Scott T., Lees A.J. Neuronal inclusions of parkinson's disease. Mov. Disord. 6:1991;2-11.
66. Giedd J.N., Jeffries N.O., Blumenthal J., Castellanos F.X., Vaituzis A.C., Fernandez T.et al. Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol. Psychiatry. 46:1999;892-898.
67. Golts N., Snyder H., Frasier M., Theisler C., Choi P., Wolozin B. Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J. Biol. Chem. 277:2002;16116-16123.
68. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in p301l tau transgenic mice induced by abeta 42 fibrils. Science. 293:2001;1491-1495.
69. Gould E., Beylin A., Tanapat P., Reeves A., Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 2:1999;260-265.
70. Guillozet A.L., Smiley J.F., Mash D.C., Mesulam M.M. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42:1997;909-918.
71. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3:1958;41-51.
72. Han X., Cheng H., Fryer J.D., Fagan A.M., Holtzman D.M. Novel role for apolipoprotein e in the central nervous system. Modulation of sulfatide content. J. Biol. Chem. 278:2003;8043-8051.
73. Han X., Holtzman D.M., McKeel D.W. Jr., Kelley J., Morris J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82:2002;809-818.
74. Herbert M.R., Harris G.J., Adrien K.T., Ziegler D.A., Makris N., Kennedy D.N.et al. Abnormal asymmetry in language association cortex in autism. Ann. Neurol. 52:2002;588-596.
75. Hildebrand C., Remahl S., Persson H., Bjartmar C. Myelinated nerve fibres in the cns. Prog. Neurobiol. 40:1993;319-384.
76. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging schizophrenia. Arch Gen. Psychiatry. 60:2003;585-594.
77. Hof P.R., Haroutunian V., Copland C., Davis K.L., Buxbaum J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res. 27:2002;1193-1200.
78. Howlin P. Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and asperger syndrome. J. Autism. Dev. Disord. 33:2003;3-13.
79. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D.et al. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein v717f (pdapp) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
80. Jansson-Verkasalo E., Ceponiene R., Kielinen M., Suominen K., Jantti V., Linna S.L.et al. Deficient auditory processing in children with asperger syndrome, as indexed by event-related potentials. Neurosci. Lett. 338:2003;197-200.
81. Jellinger K.A., Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer's disease. J. Alzheimers Dis. 3:2001;31-40.
82. Jernigan TL. White matter mapping is needed. Neurobiol Aging 2003;(this issue).
83. Kaifu T., Nakahara J., Inui M., Mishima K., Momiyama T., Kaji M.et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in dap12-deficient mice. J. Clin. Invest. 111:2003;323-332.
84. Karrass J., Braungart-Rieker J.M., Mullins J., Lefever J.B. Processes in language acquisition: the roles of gender attention, and maternal encouragement of attention over time. J. Child Lang. 29:2002;519-543.
85. Keller A., Jeffries N.O., Blumenthal J., Clasen L.S., Liu H., Giedd J.N.et al. Corpus callosum development in childhood-onset schizophrenia. Schizophr. Res. 62:2003;105-114.
86. Kemper T. Neuroanatomical and neuropathological changes during aging and dementia, 2nd ed. New York: Oxford University Press; 1994.
87. Kenigsberg R.L., Hong Y., Theoret Y. Cholinergic cell expression in the developing rat medial septal vitro is differentially controlled by gabaa and gabab receptors. Brain Res. 805:1998;123-130.
88. Kertesz A., Munoz D.G. Primary progressive aphasia and pick complex. J. Neurol. Sci. 206:2003;97-107.
89. Kiuru S., Salonen O., Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann. Neurol. 45:1999;305-311.
90. Klintworth GK. Huntington's chorea - morphologic contributions of a century. In: Barbeau A, Paulson GW, Chase TN, editors. Advances in neurology, v1: Huntington's chorea, 1872-1972. New York: Raven Press; 1973. p. 353-68.
91. Kraeplin E, Dementia praecox and paraphenia. Edinburgh, Scotland: E & S Livingstone; 1919.
92. Kurt M.A., Davies D.C., Kidd M., Duff K., Rolph S.C., Jennings K.H.et al. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp. Neurol. 171:2001;59-71.
93. Langlais P.J., Thal L., Hansen L., Galasko D., Alford M., Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without lewy bodies. Neurology. 43:1993;1927-1934.
94. Legrand C., Ghandour M.S., Clos J. Histochemical and biochemical studies of butyrylcholinesterase activity in adult and developing cerebellum. Effects of abnormal thyroid state and undernutrition. Neuropathol. Appl. Neurobiol. 9:1983;433-453.
95. Lehmann D.J., Williams J., McBroom J., Smith A.D. Using meta-analysis to explain the diversity of results in of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience. 108:2001;541-554.
96. Lewis J., Dickson D.W., Lin W.L., Chisolm L., Corral A., Jones G.et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and app. Science. 293:2001;1487-1491.
97. Lishman WA. Head injury. Organic psychiatry the psychological consequences of cerebral disorder. Oxford: Blackwell Scientific Publications, 1987. p. 137-86.
98. LoPresti P. Regulation and differential expression of tau mrna isoforms as oligodendrocytes mature in vivo: implications for myelination. Glia. 37:2002;250-257.
99. Marner L., Nyengaard J.R., Tang Y., Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J. Comp. Neurol. 462:2003;144-152.
100. McAlonan G.M., Daly E., Kumari V., Critchley H.D., van Amelsvoort T., Suckling J.et al. Brain anatomy and sensorimotor gating in asperger's syndrome. Brain. 125:2002;1594-1606.
101. McInnes A., Humphries T., Hogg-Johnson S., Tannock R. Listening comprehension and working memory are impaired in attention-deficit hyperactivity disorder irrespective of language impairment. J. Abnorm. Child Psychol. 31:2003;427-443.
102. Mesulam M.M. A plasticity-based theory of the pathogenesis of Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;42-52.
103. Mesulam M.M., Geula C., Moran M.A. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 22:1987;683-691.
104. Meyer A. Paul flechsig's system of myelogenetic cortical localization in the light of recent research in neuroanatomy and neurophysiology part ii. Can. J. Neurol. Sci. 8:1981;95-104.
105. Miguel-Hidalgo J.J., Alvarez X.A., Cacabelos R., Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res. 958:2002;210-221.
106. Mikkonen J.E., Gronfors T., Chrobak J.J., Penttonen M. Hippocampus retains the periodicity of gamma stimulation in vivo. J. Neurophysiol. 88:2002;2349-2354.
107. Miller A.K., Alston R.L., Corsellis J.A. Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser. Neuropathol. Appl. Neurobiol. 6:1980;119-132.
108. Mori F., Tanji K., Yoshimoto M., Takahashi H., Wakabayashi K. Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase k and formic acid pretreatment. Exp. Neurol. 176:2002;98-104.
109. Mostofsky S.H., Cooper K.L., Kates W.R., Denckla M.B., Kaufmann W.E. Smaller prefrontal and premotor volumes in boys with attention-deficit/ hyperactivity disorder. Biol. Psychiatry. 52:2002;785-794.
110. Noble M. Commentary: the possible role of myelin destruction as a precipitating event in Alzheimer's disease. Neurobiol Aging 2003;(this issue).
111. Norbury R., Cutter W.J., Compton J., Robertson D.M., Craig M., Whitehead M.et al. The neuroprotective effects of estrogen on the aging brain. Exp. Gerontol. 38:2003;109-117.
112. O'Brien K.K., Saxby B.K., Ballard C.G., Grace J., Harrington F., Ford G.A.et al. Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics. 13:2003;231-239.
113. O'Sullivan M., Jones D.K., Summers P.E., Morris R.G., Williams S.C., Markus H.S. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology. 57:2001;632-638.
114. Pak K., Chan S.L., Mattson M.P. Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice. Neuromol. Med. 3:2003;53-64.
115. Paloneva J., Autti T., Raininko R., Partanen J., Salonen O., Puranen M. et al. Cns manifestations of nasu-hakola disease: a frontal dementia with bone cysts. Neurology. 56:2001;1552-1558.
116. Penhune V.B., Zatorre R.J., MacDonald J.D., Evans A.C. Interhemispheric anatomical differences in human primary auditory cortex: probabilistic mapping and volume measurement from magnetic resonance scans. Cereb. Cortex. 6:1996;661-672.
117. Perry E., McKeith I., Ballard C. Butyrylcholinesterase and progression of cognitive deficits in dementia with lewy bodies. Neurology. 60:2003;1852-1853.
118. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 4:1978;273-277.
119. Peters A., Moss M.B., Sethares C. The effects of aging on layer 1 of primary visual cortex in the rhesus monkey. Cereb. Cortex. 11:2001;93-103.
120. Peters A., Sethares C. Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. J. Comp. Neurol. 442:2002;277-291.
121. Peters A., Sethares C. Is there remyelination during aging of the primate central nervous system? J. Comp. Neurol. 460:2003;238-254.
122. Peters A., Sethares C., Killiany R.J. Effects of age on the thickness of myelin sheaths in monkey primary visual cortex. J. Comp. Neurol. 435:2001;241-248.
123. Piao Y.S., Hayashi S., Hasegawa M., Wakabayashi K., Yamada M., Yoshimoto M.et al. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. Acta Neuropathol. Berl. 101:2001;285-293.
124. Posthuma D., Baare W.F., Hulshoff Pol H.E., Kahn R.S., Boomsma D.I., De Geus E.J. Genetic correlations between brain volumes and the wais-iii dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Res. 6:2003;131-139.
125. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., Davis K.L. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia. Arch Gen. Psychiatry. 55:1998;205-211.
126. Rakic P., Bourgeois J.P., Eckenhoff M.F., Zecevic N., Goldman-Rakic P.S. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. 232:1986;232-235.
127. Religa D., Laudon H., Styczynska M., Winblad B., Naslund J., Haroutunian V. Amyloid beta pathology in Alzheimer's disease and schizophrenia. Am. J. Psychiatry. 160:2003;867-872.
128. Rizzuto D.S., Madsen J.R., Bromfield E.B., Schulze-Bonhage A., Seelig D., Aschenbrenner-Scheibe R.et al. Reset of human neocortical oscillations during a working memory task. Proc. Natl. Acad. Sci. USA. 100:2003;7931-7936.
129. Roher A.E., Weiss N., Kokjohn T.A., Kuo Y.M., Kalback W., Anthony J.et al. Increased abeta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry. 41:2002;11080-11090.
130. Rouser G., Yamamoto A. Curvilinear regression course of human brain lipid composition changes with age. Lipids. 3:1968;284-287.
131. Rucklidge J.J., Tannock R. Neuropsychological profiles of adolescents with adhd: effects of reading difficulties and gender. J. Child Psychol. Psychiatry. 43:2002;988-1003.
132. Salthouse T.A. The processing-speed theory of adult age differences in cognition. Psychol. Rev. 103:1996;403-428.
133. Salthouse T.A. Aging and measures of processing speed. Biol. Psychol. 54:2000;35-54.
134. Salthouse T.A., Becker J.T. Independent effects of Alzheimer's disease on neuropsychological functioning. Neuropsychology. 12:1998;242-252.
135. Salthouse TA, Kail R. Memory development through the lifespan: the role of processing rate. In: Baltes PB, Brim OG, editors. Life-span development and behavior, vol. 5. New York: Academic Press; 1983. p. 99-116.
136. Salthouse T.A., Miles J.D. Aging and time-sharing aspects of executive control. Mem. Cognit. 30:2002;572-582.
137. Sarno S., Erasmus L.P., Lipp B., Schlaegel W. Multisensory integration after traumatic brain injury: a reaction time study between pairings of vision, touch and audition. Brain Inj. 17:2003;413-426.
138. Schmidt M.L., Zhukareva V., Newell K.L., Lee V.M., Trojanowski J.Q. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol. (Berl). 101:2001;518-524.
139. Shumaker S.A., Legault C., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L.et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. JAMA. 289:2003;2651-2662.
140. Silver LB. Developmental learning disorders. In: Fisher MG, editor. Child and adolescent psychiatry. Baltimore: Williams & Wilkins; 1991. p. 522-9.
141. Sowell E.R., Peterson B.S., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W. Mapping cortical change across the human life span. Nat. Neurosci. 6:2003;309-315.
142. Srinivasan R. Spatial structure of the human alpha rhythm: global correlation in adults and local correlation in children. Clin Neurophysiol 1999;1999:1351-62.
143. Tallal P., Miller S., Fitch R.H. Neurobiological basis of speech: a case for the preeminence of temporal processing. Ann. NY Acad. Sci. 682:1993;27-47.
144. Tang Y., Nyengaard J.R., Pakkenberg B., Gundersen H.J. Age-induced white matter changes in the human brain: a stereological investigation. Neurobiol. Aging. 18:1997;609-615.
145. Thal D.R., Rub U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K.et al. Sequence of abeta-protein deposition in the human medial temporal lobe. J. Neuropathol. Exp. Neurol. 59:2000;733-748.
146. Torp R., Head E., Cotman C.W. Ultrastructural analyses of beta-amyloid in the aged dog brain: neuronal beta-amyloid is localized to the plasma membrane. Prog. Neuropsychopharmacol. Biol. Psychiatry. 24:2000;801-810.
147. Townsend J., Westerfield M., Leaver E., Makeig S., Jung T., Pierce K.et al. Event-related brain response abnormalities in autism: evidence for impaired cerebello-frontal spatial attention networks. Brain Res. Cogn. Brain Res. 11:2001;127-145.
148. van der Flier W.M., van den Heuvel D.M., Weverling-Rijnsburger A.W., Bollen E.L., Westendorp R.G., van Buchem M.A.et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann. Neurol. 52:2002;62-67.
149. Varela F., Lachaux J.P., Rodriguez E., Martinerie J. The brainweb: phase synchronization and large-scale integration. Nat. Rev. Neurosci. 2:2001;229-239.
150. Vega W.A., Aguilar-Gaxiola S., Andrade L., Bijl R., Borges G., Caraveo-Anduaga J.J.et al. Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend. 68:2002;285-297.
151. Verhaeghen P., Salthouse T.A. Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural models. Psychol. Bull. 122:1997;231-249.
152. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348:2003;1215-1222.
153. Vinogradov S., Kirkland J., Poole J.H., Drexler M., Ober B.A., Shenaut G.K. Both processing speed and semantic memory organization predict verbal fluency in schizophrenia. Schizophr. Res. 59:2003;269-275.
154. Volkmar FR. Autism and the pervasive developmental disorders. In: Fisher MG, editor. Child and adolescent psychiatry. Baltimore: Williams & Wilkins; 1991. p. 499-508.
155. Wakabayashi K., Fukushima T., Koide R., Horikawa Y., Hasegawa M., Watanabe Y.et al. Juvenile-onset generalized neuroaxonal dystrophy (hallervorden-spatz disease) with diffuse neurofibrillary and lewy body pathology. Acta Neuropathol. (Berl). 99(3):2000;331-336.
156. Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M.et al. Accumulation of alpha-synuclein/nacp is a cytopathological feature common to lewy body disease and multiple system atrophy. Acta Neuropathol. (Berl). 96:1998;445-452.
157. Waterham H.R. Inherited disorders of cholesterol biosynthesis. Clin. Genet. 61:2002;393-403.
158. Weiss G. Attention deficit hyperactivity disorder. In: Fisher MG, editor. Child and adolescent psychiatry. Baltimore: Williams & Wilkins; 1991. p. 544-61.
159. Whitman GT, Cotman CW. Oligodendrocyte degeneration in ad. Neurobiol of Aging 2003;(this issue).
160. Wiggins R.C. Myelin development and nutritional insufficiency. Brain Res. 257:1982;151-175.
161. Wilhelmsen K.C., Lynch T., Pavlou E., Higgins M., Nygaard T.G. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55:1994;1159-1165.
162. Wolozin B., Golts N. Iron and parkinson's disease. Neuroscientist. 8:2002;22-32.
163. Wright C.I., Geula C., Mesulam M.M. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Ann. Neurol. 34:1993;373-384.
164. Wu K.K., Anderson V., Castiello U. Neuropsychological evaluation of deficits in executive functioning for adhd children with or without learning disabilities. Dev. Neuropsychol. 22:2002;501-531.
165. Yakovlev PI, Lecours AR. Regional development of the brain in early life. Boston: Blackwell Scientific Publications; 1967.
166. Ye P., Li L., Richards R.G., DiAugustine R.P., D'Ercole A.J. Myelination is altered in insulin-like growth factor-i null mutant mice. J. Neurosci. 22:2002;6041-6051.
167. Yurgelun-Todd D.A., Killgore W.D., Young A.D. Sex differences in cerebral tissue volume and cognitive adolescence. Psychol. Rep. 91:2002;743-757.
168. Zatorre R.J., Belin P., Penhune V.B. Structure and function of auditory cortex: music and speech. Trends Cogn. Sci. 6:2002;37-46.
169. Zhou R., Abbas P.J., Assouline J.G. Electrically evoked auditory brainstem response in peripherally myelin-deficient mice. Hear Res. 88:1995;98-106.